MedTrace Logo

Optical Detection of Malignancy During Percutaneous Interventions

NCT01730365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 104

Last updated 2016-04-11

No results posted yet for this study

Summary

Investigation of application possibilities of optical spectroscopy within the field of oncology. Optical spectroscopy enables the possibility to specifically differentiate between different (human) tissues. The hypothesis is that incorporation of this technique into existing medical devices (e.g. biopsy needle) would enlarge the accuracy and reliability of these devices. The purpose is to improve and speed up the diagnostics and therapy of the malignancies.

Conditions

  • Pulmonary Coin Lesion
  • Colon Cancer Liver Metastasis
  • Breast Cancer

Interventions

PROCEDURE

Core biopsy procedure

Core biopsy of suspicious lesion in lung, liver, breast, or colorectal liver metastasis.

Sponsors & Collaborators

  • Philips Healthcare

    lead INDUSTRY

Principal Investigators

  • Theo Ruers, MD · Nederlands Kanker Instituut/Antonie van leeuwenhoek Ziekenhuis

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-12-31
Completion
2015-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01730365 on ClinicalTrials.gov